This study is looking at how well a device called the Nanodropper works for people with glaucoma. The Nanodropper is an adapter that twists onto eyedrop bottles to make the drops smaller, which may reduce waste, cost, and side effects. Researchers want to see if using the Nanodropper helps people finish their glaucoma medication bottles and if they are satisfied with using it. You can join if you are 18 or older, currently using the same glaucoma eyedrops for at least two months, and are a patient at Boston University Eye Associates. The study aims to enroll 80 participants. The current recruitment status is unclear.

Study design

This is a randomized crossover study involving 80 participants. You will use the Nanodropper for one period and no drop aid for another period, with the order determined randomly.

What's involved

You will be instructed on how to use the Nanodropper. You will have an intraocular pressure check and complete satisfaction surveys at 3 weeks and after at least 6 weeks for each study period.

Compensation

Not stated in the trial record.

Follow-up

The study measures outcomes at 12 weeks, which suggests a follow-up period of at least that long.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.